Rigel Pharmaceuticals (RIGL) News Today $38.85 -0.46 (-1.17%) Closing price 04:00 PM EasternExtended Trading$38.52 -0.33 (-0.85%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RIGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Rigel to Participate in Upcoming September Investor ConferencesAugust 26 at 8:05 AM | prnewswire.comThis ‘Darling’ Pharma Stock Is Hitting New Highs, But the Momentum Could Run Out SoonAugust 25, 2025 | finance.yahoo.comThis ‘Darling’ Pharma Stock Is Hitting New HighsAugust 25, 2025 | barchart.comRigel Pharmaceuticals (NASDAQ:RIGL) Reaches New 1-Year High - What's Next?August 21, 2025 | marketbeat.comHead-To-Head Analysis: Rigel Pharmaceuticals (NASDAQ:RIGL) vs. Lipocine (NASDAQ:LPCN)August 21, 2025 | americanbankingnews.comRigel Pharmaceuticals (NASDAQ:RIGL) Sees Strong Trading Volume - Should You Buy?August 20, 2025 | marketbeat.comAnalysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) PT at $38.20August 19, 2025 | americanbankingnews.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Hold" from BrokeragesAugust 17, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Trading Up 3.3% - Should You Buy?August 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)August 16, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Sets New 12-Month High - Time to Buy?August 14, 2025 | marketbeat.comRigel Pharmaceuticals: Q2 Earnings Fuel A Potential BreakoutAugust 13, 2025 | seekingalpha.comRigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable QualityAugust 13, 2025 | finance.yahoo.comH.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PTAugust 12, 2025 | finance.yahoo.comRigel Pharmaceuticals (NASDAQ:RIGL) Sees Unusually-High Trading Volume - Time to Buy?August 10, 2025 | marketbeat.comRIGL FY2025 EPS Forecast Increased by Cantor FitzgeraldAugust 9, 2025 | marketbeat.comHC Wainwright Issues Optimistic Estimate for RIGL EarningsAugust 9, 2025 | marketbeat.comResults: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesAugust 8, 2025 | finance.yahoo.comRigel Pharmaceuticals (NASDAQ:RIGL) Hits New 1-Year High Following Analyst UpgradeAugust 8, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comRigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Expected to Rise, Cantor Fitzgerald Analyst SaysAugust 7, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up After Strong EarningsAugust 7, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings ResultsAugust 6, 2025 | marketbeat.comRigel (RIGL) Q2 Revenue Jumps 176%August 6, 2025 | theglobeandmail.comRigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look ForAugust 6, 2025 | finance.yahoo.comRigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ...August 6, 2025 | gurufocus.comRigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40August 6, 2025 | msn.comRigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comRigel Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.comRigel Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 5, 2025 | prnewswire.comWith 65% institutional ownership, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a favorite amongst the big gunsAugust 3, 2025 | finance.yahoo.comGSA Capital Partners LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)August 2, 2025 | marketbeat.comRigel Pharmaceuticals (RIGL) Expected to Announce Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comPacer Advisors Inc. Invests $2.03 Million in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)July 30, 2025 | marketbeat.comRigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business UpdateJuly 29, 2025 | prnewswire.comMassachusetts Financial Services Co. MA Purchases New Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)July 22, 2025 | marketbeat.com38,045 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Purchased by Jackson Creek Investment Advisors LLCJuly 19, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL)July 10, 2025 | insidermonkey.comRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)July 7, 2025 | prnewswire.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Rating of "Hold" by BrokeragesJune 27, 2025 | marketbeat.comRIGL Rigel Pharmaceuticals, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comRigel Pharmaceuticals (NASDAQ:RIGL) shareholders have earned a 99% return over the last yearJune 21, 2025 | finance.yahoo.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Stake Boosted by GAMMA Investing LLCJune 21, 2025 | marketbeat.comRigel Pharmaceuticals' SWOT analysis: promising pipeline drives stock potentialJune 14, 2025 | investing.comAssenagon Asset Management S.A. Buys 112,003 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 14, 2025 | marketbeat.comCantor Fitzgerald Weighs in on RIGL FY2026 EarningsJune 10, 2025 | marketbeat.comWellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 8, 2025 | marketbeat.comTwo Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 6, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLCJune 6, 2025 | marketbeat.comMillennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 5, 2025 | marketbeat.com Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RIGL Media Mentions By Week RIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼0.831.04▲Average Medical News Sentiment RIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼44▲RIGL Articles Average Week Get the Latest News and Ratings for RIGL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Novavax News Innoviva News MannKind News Dynavax Technologies News OPKO Health News Geron News Zenas BioPharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access